O4-03-08: Efficacy and safety of MPC-7869 (R-flurbiprofen),...

Alzheimer's & Dementia 2006 Vol. 2; Iss. 3-supp-S

O4-03-08: Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective Aβ42-lowering agent, in Alzheimer’s disease (AD): Results of a 12-month phase 2 trial and 1-year follow-on study

Gordon K. Wilcock, Sandra E. Black, Judith Haworth, Suzanne B. Hendrix, Mark Laughlin, Kenton H. Zavitz, Daniel Christensen, Sheron Bass, Edward Swabb
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Year:
2006
Language:
english
DOI:
10.1016/j.jalz.2006.05.316
File:
PDF, 112 KB
english, 2006
Conversion to is in progress
Conversion to is failed